small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 36 results

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

ERISA Litigation

As a firm of choice for many major businesses, we represent employers, fiduciaries, boards of directors, benefit plans, and plan administrators in all aspects of ERISA litigation, including claims relating to fiduciary liability, plan investments, excessive fees, plan qualification, plan termination, reversion of excess assets, retiree medical benefits, severance and employment contract matters, tax liability matters, and retirement and welfare benefit claims....Read more

Experience 33 results

Experience

|

November 15, 2024

Winston Represented Revelstoke Capital Partners in Acquisition of NKMD MGMT, LLC

Winston represented Revelstoke Capital Partners, a healthcare-focused private equity firm, in the acquisition of NKMD Mgmt, LLC, a provider of services including fillers, toxins, and other aesthetics treatments in over 20 locations across California, Arizona and Nevada. As the medical aesthetics industry continues to grow, this partnership between Revelstoke and NKMD will help build an industry leader with a strong commitment to clinical quality, safety, and patient experience....Read more

Experience

|

November 11, 2024

Court Square Capital Partners in its Definitive Agreement to Sell Advanced Diabetes Supply Group for US$1.1B

A team led by Craig Godshall and Matthew Schlosser represented Court Square Capital Partners, a New York-based leading middle-market private equity company, in its entry into a definitive agreement to sell Advanced Diabetes Supply® Group, a California-based national distributor of Durable Medical Equipment specializing in diabetes supplies, to Cardinal Health for US$1.1B. This sale will allow ADSG to continue to expand its reach and enhance the way it serves its approximately 500,000 patients nationwide with advances in in-home delivery of diabetes products including continuous glucose monitoring devices and other testing supplies....Read more

Experience

|

September 25, 2024

Winston represents  the founding partners of EDL in a new LBO

Winston & Strawn Paris is advising the founding partners of EDL in the sale of a majority stake to Dentressangle Participations....Read more
View All Experience

Insights & News 775 results

False Claims Act Playbook

|

March 23, 2026

|

9 Min Read

Alabama Court Dismisses Hospice Whistleblower Suit, Reinforcing Pleading Standards and First-to-File Protections Under the FCA

On February 19, 2026, the United States District Court for the Middle District of Alabama dismissed a declined qui tam whistleblower suit brought against Comfort Care Hospice, LLC, and several related hospice and home health service providers based in Alabama and Tennessee, claiming improper billing practices in violation of the False Claims Act and the Tennessee Medicaid False Claims Act.

False Claims Act Playbook

|

March 23, 2026

|

10+ Min Read

Future FCA Enforcement Expectations in Light of Record-Breaking FY 2025 Recoveries and Administration Priorities

The annual False Claims Act (FCA) recovery statistics issued by the U.S. Department of Justice (DOJ) for Fiscal Year 2025 represent the highest single-year recovery in FCA history, underscoring that the FCA remains one of the government’s most effective tools for combating frauds involving federal funds. Winston attorneys outline expectations for FCA enforcement in 2026 and beyond based on an analysis of FY 2025 FCA activity and the priorities and goals of the current administration.

Competition Corner

|

March 12, 2026

|

4 Min Read

California and Rhode Island Latest States to Expand Premerger Notification Requirements

States continue to implement new premerger notification regimes and expand the scope of existing requirements, with California and Rhode Island recently adding new premerger notification requirements that dealmakers must navigate to successfully complete transactions.

View All Insights & News

Other Results 20 results

Law Glossary

What Is the FDA?

The FDA stands for the Food and Drug Administration. It is a federal agency charged with protecting the public by regulating the safety and security of drugs, biological products, veterinary medications, and medical devices. FDA responsibilities also cover the safety of: foods for U.S. consumers, cosmetics, animal feed, and radiation-emitting products. Various rules may be established and enforced by the agency in response to U.S. laws or presidential executive orders....Read more

Site Content

What Is Failure to Warn?

In the product liability context, a failure to warn claim arises when a plaintiff alleges that a product lacked an adequate warning regarding potential risks associated with its use. To succeed in a failure to warn claim, a plaintiff typically needs to demonstrate that the lack of a warning regarding a particular potential harm rendered the product unreasonably dangerous, and that adequate warnings would have ultimately prevented the alleged harm....Read more

Law Glossary

What Is Consumer Privacy Law?

Consumer privacy law is the legal area covering violations of personal information and the right to privacy in everyday life, including violations relating to technology use and finances. Consumer privacy laws and regulations protect individuals from privacy loss due to the failures and limitations of corporate customer privacy measures. The Federal Trade Commission (FTC) is the primary agency directing federal privacy policies and enforcing associated regulations. The FTC utilizes law enforcement, creates policy, and educates consumers as it acts to protect privacy. Legal action can be taken against organizations that violate consumer privacy rights, especially regarding sensitive information....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising